Nestle invests $200 million more in Aimmune after peanut allergy drug approval

Saumya Joseph of Reuters reports Aimmune Therapeutics Inc said on Wednesday the health science arm of Nestle SA will invest an additional $200 million, days after the drugmaker won U.S. approval for its peanut allergy therapy, touted as a potential blockbuster.

The funding brings Nestle’s total investment to $473 million, increasing the Swiss company’s stake to 19.9% of Aimmune’s outstanding stock and voting power.

Aimmune shares rose 5.7% in early morning trading, after falling 11% on Tuesday. Its therapy, Palforzia, was approved on Friday after markets close.

Nestle’s investment is an incremental positive for Aimmune’s shares, which have seen some weakness due to investor worries over financing, Piper Sandler analyst Christopher Raymond wrote in a note.

“With this additional investment, we think the prospect of an outright take out by Nestle (or anyone else for that matter) has to be factored in more than before,” Raymond said.

Nestle has been trying to become a “nutrition, health and wellness” company, with its Nestle Health Science unit playing a pivotal role, as packaged food sales slow amid changing tastes.

The unit invested $145 million in Aimmune in 2016, followed by $30 million as part of the drugmaker’s public offering in February 2018, and another $98 million in November 2018.

Aimmune would use the latest Nestle investment to fund the launch of Palforzia, which is the first approved therapy for reducing and potentially eliminating allergic reactions to peanuts in children.

UK restaurant owner faces manslaughter charge in fatal peanut allergy case

The owner of an Indian restaurant accused of the manslaughter of a customer who suffered a fatal allergic reaction to peanuts after eating a meal is due to appear in court.

paul.wilson.peanut.allergyMohammed Zaman, 52, owner of the Indian Garden in Easingwold, North Yorkshire, is due to enter pleas at Teesside Crown Court today after he was charged over the death of Paul Wilson (right).

The 38-year-old customer suffered a severe anaphylactic reaction and died after buying a curry from the restaurant in January last year. It was claimed he requested no nuts.

As well as manslaughter by gross negligence, the restaurant boss is charged with perverting the course of justice by forging a food safety training certificate, an immigration offence relating to the employee who served the contaminated meal, and food safety offences.

Zaman, from Huntington, York, was granted bail at a previous hearing.

Mom of peanut allergy victim: Her last words were ‘I’m sorry’

Louis and Joanne Giorgi sat together in the backyard of their Carmichael home Wednesday morning. They held each others’ hands and clutched tissues as they spoke publicly for the first time since their 13-year old daughter died from an allergic reaction to a dessert treat they had no idea contained peanuts.

“To have lost her is devastating,” Joanne Giorgi told KCRA 3’s Mike TeSelle.

KCRA Channel 3 reports Natalie Giorgi’s parents are speaking publicly in hopes of using their daughter’s death as a push for change, and a vehicle for educating the public about peanut-victim2-JPGthe seriousness of food allergies.

“This can be a catalyst for a paradigm shift, much the way seat belt use has changed since when we were kids,” Louis Giorgi said.

Natalie Giorgi died July 26 after eating a Rice Krispie treat that had been prepared with peanut products at Camp Sacramento on the final day of a multi-family camping trip, her parents said.

Giorgi had a documented allergy to peanuts.

“We had been there before. We had eaten their Rice Krispie treats before. We had never had a problem before,” Louis Giorgi said.

Giorgi said immediately after taking one bite of the treat, his daughter told her parents.

She had been dancing with friends when she took the bite.

“We gave her Benadryl like we’d been told,” Natalie’s father said.

Over the next several minutes, the Giorgis said their daughter showed no signs of a reaction whatsoever.

“I kept asking, ‘are you OK?’ She kept telling me she was fine, and she wanted to go back to dancing with her friends,” Natalie’s mom said. 

Natalie kept asking her parents to go back to her friends, but they kept telling her she had to stay with them, to make sure she was OK.

“Then suddenly, she started vomiting,” Louis said. “It spiraled downhill out of control so quickly.”

Natalie’s father, a physician, administered both of the EPI-Pens — used to slow or stop an allergic reaction — that the family carried with them.

A third was obtained from the camp and administered. None of them stopped her reaction. Her dad called 911.

“I did everything right, in my opinion. I couldn’t save her,” Louis Giorgi said.

Emergency responders who arrived later couldn’t save her, either.

“She had been fine, and had been talking to us. This was a worst-case scenario. One of the last things she said was, ‘I’m sorry mom,'” Natalie mother said as she wiped a tear away from her cheek.

The Giorgis said one of the many reasons they are sharing Natalie’s story is to convince skeptical parents that food allergies in children is very real.

More information can be found at Nateam.org.